Raymond James Financial Inc Biotechnology

Raymond James Financial Inc

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
ELEV Elevation Oncology, Inc.	$8.39M	$0 0.0% of portfolio	2	Q2 2025 New
ENTA Enanta Pharmaceuticals Inc	$155M	$0 0.0% of portfolio	50	Q2 2025 New
ENLV Enlivex Therapeutics Ltd.	$19.3M	$0 0.0% of portfolio	57	Q2 2025 New
GBIO Generation Bio Co.	$330M	$0 0.0% of portfolio	600	Q2 2025 New
GOSS Gossamer Bio, Inc.	$299M	$0 0.0% of portfolio	270	Q2 2025 New
IDYA Ideaya Biosciences, Inc.	$1.18B	$0 0.0% of portfolio	34	Q2 2025 New
IMCR Immunocore Holdings PLC	$1.47B	$0 0.0% of portfolio	22	Q2 2025 New
MAIA Maia Biotechnology, Inc.	$17.6M	$0 0.0% of portfolio	100	Q2 2025 New
NERV Minerva Neurosciences, Inc.	$11.7M	$0 0.0% of portfolio	25	Q2 2025 New
PMCB Pharma Cyte Biotech, Inc.	$21M	$0 0.0% of portfolio	44	Q2 2025 New
PLRX Pliant Therapeutics, Inc.	$74.5M	$0 0.0% of portfolio	12	Q2 2025 New
PMVP Pmv Pharmaceuticals, Inc.	$52M	$0 0.0% of portfolio	200	Q2 2025 New
TARA Protara Therapeutics, Inc.	$34.9M	$0 0.0% of portfolio	271	Q2 2025 New
RLYB Rallybio Corp	$19.3M	$0 0.0% of portfolio	850	Q2 2025 New
RLMD Relmada Therapeutics, Inc.	$47.8M	$0 0.0% of portfolio	587	Q2 2025 New
RPTX Repare Therapeutics Inc.	$74.2M	$0 0.0% of portfolio	230	Q2 2025 New
STTK Shattuck Labs, Inc.	$76.3M	$0 0.0% of portfolio	250	Q2 2025 New
STRO Sutro Biopharma, Inc.	$46.4M	$0 0.0% of portfolio	500	Q2 2025 New
TLSA Tiziana Life Sciences LTD	$172M	$0 0.0% of portfolio	500	Q2 2025 New
VALN Valneva Se	$617M	$0 0.0% of portfolio	41	Q2 2025 New

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Raymond James Financial Inc with notifications on news.